Clinical Trials Browser

Bulbo-Spinal Atrophy, X-Linked

NCT06764485 2026-01-28

rechARge

Phase 3 Recruiting

960 enrolled

Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT07336446 2026-01-13

ANDROMEDA

Phase 1/2 Not yet recruiting

300 enrolled

Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT04090528 2025-12-05

pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

Phase 2 Active not recruiting

60 enrolled 10 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT06365788 2025-09-04

ABBICAR

Phase 2 Recruiting

53 enrolled

Breast

Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms

NCT05694819 2025-05-22

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

Phase 2 Active not recruiting

56 enrolled

Head & Neck

Salivary Gland Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT04926181 2025-05-15

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

Phase 2 Terminated

2 enrolled 12 charts

GenitourinaryThoracic

Prostatic Neoplasms, Carcinoma, Small Cell, Bulbo-Spinal Atrophy, X-Linked, Small Cell Lung Carcinoma

NCT05241613 2025-02-13

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Phase 1 Terminated

28 enrolled

Bulbo-Spinal Atrophy, X-Linked

NCT01969578 2024-11-05

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

Phase 2 Completed

149 enrolled

Head & Neck

Adenocarcinoma, Salivary Gland Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT04869943 2024-01-26

ARTEST

Phase 3 Terminated

52 enrolled

Breast

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT05673109 2024-01-25

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Phase 1 Terminated

8 enrolled

Bulbo-Spinal Atrophy, X-Linked

NCT03437941 2023-05-06

Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC

Phase 1/2 Completed

39 enrolled

Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT03050866 2021-08-20

CABA-V7

Phase 2 Unknown

140 enrolled

Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT03478904 2021-05-10

Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

Phase 1 Terminated

1 enrolled 8 charts

Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT02162836 2020-04-27

A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer

Phase 1 Completed

6 enrolled

Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked, Prostatic Neoplasms, Castration-Resistant

NCT02348281 2018-01-23

Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients

Phase 2 Terminated

1 enrolled

Breast

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms

NCT02910050 2017-12-22

BETTER

Phase 2 Unknown

58 enrolled

Breast

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT00365599 2014-11-21

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

Phase 2 Completed

43 enrolled 8 charts

Breast

Breast Neoplasms, Neoplasm Metastasis, Bulbo-Spinal Atrophy, X-Linked

NCT00918385 2014-10-29

ARS

Phase 2 Terminated

57 enrolled 8 charts

Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT01351688 2013-07-03

An Open Label Prostate Cancer Study in Japanese Patients

Phase 1 Completed

13 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT01337518 2012-12-18

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Phase 1 Suspended

150 enrolled

Genitourinary

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Clinical Trials

TulmiSTAR-02

rechARge

ANDROMEDA

pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

ABBICAR

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

ARTEST

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC

CABA-V7

Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer

Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients

BETTER

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

ARS

An Open Label Prostate Cancer Study in Japanese Patients

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer